This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oaktree Fund Administration, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Dan Devine
Introduction
Dan Devine is a notable inventor based in New York, NY (US). He has made significant strides in the field of medical technology, particularly in cancer treatment. His work focuses on the use of mesenchymal lineage precursor cells or stem cells for the delivery of oligonucleotides.
Latest Patents
Dan Devine holds a patent for the "Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer." This innovative approach has the potential to enhance therapeutic outcomes for cancer patients.
Career Highlights
Devine is currently associated with Oaktree Fund Administration, LLC, where he applies his expertise in developing cutting-edge solutions. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Dan has collaborated with esteemed colleagues such as Peter Brink and Silviu Itescu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Dan Devine's contributions to the field of cancer treatment through his innovative patent demonstrate his dedication to improving patient outcomes. His work continues to inspire advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile